+31 (0)50 211 03 48
Prof. M. Oudkerk, MD, PhD
Prof. Oudkerk is responsible for the Research & Development of iDNA.
He is professor of Radiology at the University of Groningen, Chief Scientific Officer of the Institute for Diagnostic Accuracy- iDNA (formerly of the Center of Medical Imaging NORTH EAST NETHERLANDS , NWO research Center of Exellence) and the principal investigator for Radiology of the NELSON lung cancer detection study, the Robinsca cardiovascular screening study and the 4Lungrun Horizon 2020 study. Founder and past president of the European Society of Cardiac Radiology and former Chairman of Radiology departments of DDHK Erasmus MC Rotterdam and University Medical Center Groningen. Prof. Oudkerk has a broad insight into new imaging modalities, algorithms and strategies. He is ranked as one the most influential researchers in Radiology in Europe (2019). For his research work he received prestigious grants such as EU Horizon 2020, ERC advanced grant, Royal Academy of Sciences of the Netherlands (KNAW), Ministry of Science and Technology of China (MOST), NWO, KWF, NKB grants etc.
He is lead investigator of the NELSON lung cancer detection study, the ROBINSCA study for coronary disease detection, NELCIN B3 study in China focusing on lung cancer , coronary artery disease and pulmonary disease in one imaging test. Prof. Oudkerk was invited as a member of the medical advisory board of Siemens AG Germany for development of the first continuous rotating spiral CT and has been part of this board until the development of the current volume multi-detector CT scanners pushing forward the need for higher temporal resolutions in CT scanning comparable with EBT. With his research team he initiated the field of CT coronary imaging; Prof. Oudkerk is inspiring many (inter-)national students to start their PhD research in his Institute, resulting in several PhD defenses per year.
Prof Oudkerk published more than 555 peer reviewed articles, is cited over 20,000 times with an H-index >74 (Scopus). Key publications in NEJM, Lancet, Thorax, Circulation, JACC, Eur Heart, Radiology, Lancet Oncology, etc.
+31 (0)6 21 55 19 99
Erik Jippes, PhD, MBA
Erik Jippes is responsible for the day-to-day operation of iDNA.
Erik’s background working in a medical academic environment, and with medical imaging in particular, enables him to understand and act on the complexities in hospital environments. This is of great importance for implementing lung cancer screening programmes.
Erik has a Master of Business Administration and holds a PhD in social networks and innovation processes in healthcare. He worked for more than 14 years at a University Medical Center and was responsible for several large public–private partnerships, pre- and post-award project management for funding support (H2020, national and regional grants), and charity fundraising.
He was manager of several large-scale population-based early detection and screening trials in lung cancer and cardiovascular diseases.
In his spare time Erik likes to travel with his wife and three children, and he loves to play beach volleyball.
+31 (0)6 24 21 71 13
Evgeni Dvortsin, MSc
Evgeni Dvortsin is a health economist and healthcare entrepreneur, responsible for leading the development and execution of the long-term strategies of iDNA.
His background as a founder of Asc Academics — a globally operating health economics and market access consultancy — provides an excellent knowledge foundation in cost-benefit analyses in healthcare. This is of the utmost importance for the implementation of lung cancer early detection and screening programs. In addition, Evgeni co-founded the General Practitioners Research Institute (GPRI), which aims to improve the lives of patients by facilitating participation in real world evidence generation studies.
Evgeni has a background as a pharmacist and pharmaceutical scientist at the University of Groningen, and, in his rare moments of spare time, he enjoys everything related to basketball.
+31 (0)6 42 29 99 19
Jie Hui Chen, MBA
Jie Hui Chen is responsible for the strategic partnerships and relations with Asia. She is also responsible for the day-to-day operation for iDNA Asia.
Jie Hui is an entrepreneur who has more than 15 years of experience in bridging Asian and Dutch companies. She studied Asian Business Studies and obtained an MBA certificate from national Sun Yat Sen University in Taiwan. She is an expert in Chinese language and culture and has an extensive network within Asia. Since 2016, Jie Hui has been the liaison manager between hospitals in China and the Netherlands for several large-scale population-based early detection and screening studies in lung cancer and cardiovascular diseases.
Moreover, she has a personal motivation; her grandmother in China passed away from lung cancer. This inspires her to give her best every day for iDNA.
Jie Hui likes to travel and explore new cultures with her husband and two children.